Fundraising FoxNovartis Institute for Biomedical Research
Seed · 1 people tracked
Find your way into Novartis Institute for Biomedical Research
748 people in our graph can introduce you to the Novartis Institute for Biomedical Research team.
Sign up to see every warm intro you have to Novartis Institute for Biomedical Research
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novartis Institute for Biomedical Research team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The Novartis Institute for Biomedical Research is the research organization of Novartis, with roughly 6,000 scientists and R&D sites worldwide, and it invests at multiple stages internationally. Its priority disease areas are oncology, neuroscience, immunology, and cardiovascular and metabolic disease, with functional groups covering global discovery chemistry, chemical biology and therapeutics, translational medicine and digital.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 2 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×2Deep Tech ×1Digital Health ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathCadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsQiming Venture Partners USASlater Technology FundAccess IndustriesAtlas VentureClal Biotechnology IndustriesCowen Healthcare Investments+1 more
Perlara is a biopharmaceutical company that develops treatments for ultra-rare genetic diseases using yeast-based disease modeling and drug repurposing strategies.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Ethan Perlstein(CEO and founder)in
BoardMatthew Wilsey(Director)Linda Avey(Director)
Co-investorsY CombinatorAgrolimen VenturesHaystackHomebrewLemonade CapitalMicroVentures+2 more
Exits · 1
1 acquisitionsCadenttxacq. by Novartis
Frequently asked questions
- What stage does Novartis Institute for Biomedical Research invest at?
- Novartis Institute for Biomedical Research invests at the Seed stage.
- What sectors does Novartis Institute for Biomedical Research focus on?
- Novartis Institute for Biomedical Research focuses on Healthtech.
Similar investors
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.